The leptin/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway is significantly associated with the pathogenesis of hyperlipidemia via alterations in lipid metabolites. The gene discussed is JAK2; the disease is hyperlipidemia.